FDA appropriations
Executive Summary
Senate passes FY 2004 Agriculture Appropriations bill Nov. 6 by a vote of 93 to 1, including a budget for FDA of $1.4 bil. One amendment specifies that a minimum of $52.8 mil. would be available for FDA's generic drug program, in keeping with the House-passed language (1"The Pink Sheet" July 7, 2003, In Brief)...
You may also be interested in...
FDA generic drug appropriations
House Appropriations Committee recommends increase of $8 mil. for FDA's generic drug program in FY 2004 Agriculture Appropriations bill report. The committee's recommendation is $5 mil. less than the increase requested in President Bush's FY 2004 budget (1"The Pink Sheet" Jan. 27, 2003, p. 15)...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.